You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TEVA Sale Disclosure
Kalif Eliyahu Sharon · SEC Form 4 · Filed Jun 16, 2026
Sale
Calculated transaction value
$3.63M
Kalif Eliyahu Sharon EVP, Chief Financial Officer
TEVA
Transaction date
Jun 11, 2026
Public filing date
Jun 16, 2026
Filing lag
Filed 5 days later
TEVA daily price context
Close on/before transaction
$34.56
Jun 11, 2026
First close after public filing
$32.56
Jun 17, 2026
30-day return after filing
-1.04%
Through Jul 16, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 106,563 shares @ $34.1
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-271862
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$3.63M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd TEVA Current | Sale | Jun 11, 2026 | $3.63M |